Phibro Animal Health (NASDAQ:PAHC) Downgraded to “Hold” Rating by StockNews.com

StockNews.com lowered shares of Phibro Animal Health (NASDAQ:PAHC) from a buy rating to a hold rating in a research note published on Friday morning.

A number of other equities research analysts also recently weighed in on PAHC. Morgan Stanley lifted their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Barclays lifted their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research report on Monday, February 10th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. According to data from MarketBeat, Phibro Animal Health currently has an average rating of “Hold” and a consensus target price of $21.00.

Phibro Animal Health Stock Up 1.4 %

NASDAQ PAHC opened at $23.64 on Friday. The company has a current ratio of 3.20, a quick ratio of 1.37 and a debt-to-equity ratio of 2.99. Phibro Animal Health has a 1-year low of $11.98 and a 1-year high of $26.55. The company has a 50 day moving average of $22.47 and a 200-day moving average of $22.48. The company has a market cap of $957.49 million, a price-to-earnings ratio of 49.25, a PEG ratio of 0.45 and a beta of 0.52.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, equities research analysts expect that Phibro Animal Health will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be given a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $0.48 annualized dividend and a yield of 2.03%. Phibro Animal Health’s dividend payout ratio is currently 100.00%.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the company. Sterling Capital Management LLC raised its position in Phibro Animal Health by 2.4% during the fourth quarter. Sterling Capital Management LLC now owns 18,762 shares of the company’s stock valued at $394,000 after purchasing an additional 448 shares in the last quarter. Rhumbline Advisers grew its stake in shares of Phibro Animal Health by 0.6% during the fourth quarter. Rhumbline Advisers now owns 76,582 shares of the company’s stock worth $1,608,000 after buying an additional 484 shares during the last quarter. Los Angeles Capital Management LLC grew its stake in shares of Phibro Animal Health by 2.1% during the fourth quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company’s stock worth $505,000 after buying an additional 503 shares during the last quarter. BNP Paribas Financial Markets grew its stake in shares of Phibro Animal Health by 3.1% during the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after buying an additional 729 shares during the last quarter. Finally, New York State Teachers Retirement System grew its stake in shares of Phibro Animal Health by 16.7% during the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock worth $114,000 after buying an additional 775 shares during the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.